A detailed history of Advisor Partners Ii, LLC transactions in Repligen Corp stock. As of the latest transaction made, Advisor Partners Ii, LLC holds 2,031 shares of RGEN stock, worth $256,027. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,031
Previous 1,905 6.61%
Holding current value
$256,027
Previous $269,000 19.7%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

BUY
$138.78 - $176.51 $17,486 - $22,240
126 Added 6.61%
2,031 $322,000
Q2 2023

Aug 10, 2023

SELL
$138.42 - $180.31 $22,562 - $29,390
-163 Reduced 7.88%
1,905 $269,000
Q1 2023

May 15, 2023

BUY
$154.26 - $198.1 $31,006 - $39,818
201 Added 10.77%
2,068 $348,000
Q4 2022

Feb 14, 2023

BUY
$162.42 - $220.56 $22,738 - $30,878
140 Added 8.11%
1,867 $316,000
Q3 2022

Nov 14, 2022

BUY
$160.42 - $256.21 $277,045 - $442,474
1,727 New
1,727 $323,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Advisor Partners Ii, LLC Portfolio

Follow Advisor Partners Ii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners Ii, LLC with notifications on news.